Key result
Impella-supported PCI survival to discharge reaches ~97% electively but drops to ~48% in AMI-CS.
Why the study?
What are the patient profiles, procedural complexity, and survival outcomes of Impella CP-supported percutaneous coronary intervention in patients undergoing elective high-risk PCI (with preserved or reduced LVEF) compared to those with acute myocardial infarction-related cardiogenic shock?
Observational (n=69)
No
What are the patient profiles, procedural complexity, and survival outcomes of Impella CP-supported percutaneous coronary intervention in patients undergoing elective high-risk PCI (with preserved or reduced LVEF) compared to those with acute myocardial infarction-related cardiogenic shock?
In this single-center registry, Impella CP facilitated complex revascularization with high survival to discharge in elective high-risk PCI (77.8% in preserved LVEF and 96.8% in reduced LVEF), whereas patients with AMI-related cardiogenic shock frequently required ECPELLA (44.8%) and had lower survival to discharge (48.3%).
Answers are grounded in this paper and cite their sources.
Survival varies widely by indication in Impella-supported PCI; hypothesis-generating and leaves open optimal selection pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Reschner et al. (2026) conducted an observational in Elective high-risk percutaneous coronary intervention and acute myocardial infarction-related cardiogenic shock (n=69). Impella CP-supported PCI in AMI-CS vs. Impella CP-supported elective high-risk PCI in reduced LVEF (n=31) and preserved LVEF (n=9) was evaluated on Survival to discharge (p=<0.001). Impella CP-supported PCI yielded survival to discharge of 77.8% in elective preserved-LVEF, 96.8% in elective reduced-LVEF, and 48.3% in AMI-CS patients.
Synapse has enriched 10 related papers. Consider them for comparative context: